CPAP for the Treatment of Supine Hypertension
NCT: NCT05489575 · RECRUITING
Brief Summary
This study aims to learn about the effects of continuous positive airway pressure (CPAP) on people with autonomic failure and high blood pressure when lying down (supine hypertension) to determine if it can be used to treat their high blood pressure during the night. CPAP (a widely used treatment for sleep apnea) involves using a machine that blows air into a tube connected to a mask covering the nose, or nose and mouth, to apply a low air pressure in the airways. The study includes 3-5 days spent in the Vanderbilt Clinical Research Center (CRC): at least one day of screening tests, followed by up to 3 study days. Subjects may be able to participate in daytime and/or overnight studies. The Daytime study consists of 2 study days: one with active CPAP and one with sham CPAP applied for up to 2 hours. The Overnight study consists of 3 study nights: one with active CPAP, one with sham CPAP, both applied for up to 9 hours and one night sleeping with the bed tilted head-up.
Frequently Asked Questions
What is CPAP for the Treatment of Supine Hypertension?
CPAP for the Treatment of Supine Hypertension is a clinical trial registered under NCT05489575. Current status: RECRUITING.
What is the status of NCT05489575?
The current status of NCT05489575 (CPAP for the Treatment of Supine Hypertension) is: RECRUITING.
When did CPAP for the Treatment of Supine Hypertension start?
CPAP for the Treatment of Supine Hypertension started on 2022-06-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.